More than a million COVID deaths in 4 months since G7 leaders failed to break vaccine monopolies - World
English News and Press Release on World about Health and Epidemic; published on 03 Jun 2021 by Oxfam
Stay updated with breaking news from Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
English News and Press Release on World about Health and Epidemic; published on 03 Jun 2021 by Oxfam
Seven Reasons the EU is Wrong to Oppose the TRIPS Waiver People wait to get tested for Covid-19 in Hyderabad, India, April 25, 2021. © 2021 AP Photo/Mahesh Kumar A. As the Covid-19 pandemic has devastating human rights, social, and economic consequences across the globe, European Union (EU) representatives have repeatedly stated their commitment to the idea that Covid-19 vaccines should be a universal common good and that no one is safe from Covid-19 unless everyone is safe. Yet the EU has consistently opposed India and South Africa’s proposal at the Wo...
Yet the EU has consistently opposed India and South Africa's proposal at the World Trade Organization to temporarily waive certain intellectual property rules under the Agreement on Trade-Related Aspects of Intellectual Property Rights, a measure that would expand access to lifesaving vaccines and other health products. The arguments used by the...
Jayati Ghosh The decision by Joe Biden’s administration to stop opposing a proposed Covid-19 waiver of certain intellectual-property rights under World Trade Organization rules is a welcome move. The United States trade representative, Katherine Tai, acknowledges that ‘the extraordinary circumstances of the Covid-19 pandemic call for extraordinary measures’. While affirming that it ‘believes strongly in intellectual property protections’, the Biden administration ‘in service of ending this pandemic, supports the waiver of those protections for Covid-19 vaccines’. Already, the US...
There has been impressive progress on the vaccination front. Scientists have come up with multiple vaccines in record time. Unprecedented public and private financing has supported vaccine research, development and manufacturing scale-up.